Semi-Solid Dosage CDMO Market Report 2024-2030: The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals Dominate the Competitive Landscape
Portfolio Pulse from
The global semi-solid dosage CDMO market is projected to grow significantly, reaching USD 67.4 billion by 2030 with a CAGR of 11.80% from 2024 to 2030. Key players include The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals.
November 13, 2024 | 4:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cambrex Corporation is highlighted as a key player in the growing semi-solid dosage CDMO market, expected to reach $67.4 billion by 2030.
Cambrex Corporation is directly mentioned as a dominant player in a rapidly growing market, which is likely to positively impact its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80